1463502-41-1 Usage
General Description
Tert-butyl 3-(prop-2-yn-1-yl)azetidine-1-carboxylate is a chemical compound with the molecular formula C11H17NO2. It is a derivative of azetidine, a four-membered heterocyclic compound containing one nitrogen atom. tert-butyl 3-(prop-2-yn-1-yl)azetidine-1-carboxylate is a carboxylate ester, meaning it contains a carbonyl group bonded to an oxygen atom and an alkyl group. The presence of the prop-2-yn-1-yl group indicates that it contains a triple bond between the second and third carbon atoms. This chemical may have applications in organic synthesis and pharmaceutical research, as well as potential industrial and commercial uses.
Check Digit Verification of cas no
The CAS Registry Mumber 1463502-41-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,6,3,5,0 and 2 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1463502-41:
(9*1)+(8*4)+(7*6)+(6*3)+(5*5)+(4*0)+(3*2)+(2*4)+(1*1)=141
141 % 10 = 1
So 1463502-41-1 is a valid CAS Registry Number.
1463502-41-1Relevant articles and documents
?-LACTAMASE INHIBITOR AND USE THEREOF
-
Paragraph 0206; 0209, (2020/12/10)
Provided are a β-lactamase inhibitor of formula (I), or an ester, a stereoisomer or a pharmaceutically acceptable salt thereof, and a method of preparing the same. Further provided is a pharmaceutical composition comprising the β-lactamase inhibitor of formula (I), or the ester, the stereoisomer or pharmaceutically acceptable salt thereof. In addition, the present invention relates to a method for treating diseases caused by bacterial infection, which comprises administering the β-lactamase inhibitor of formula (I), or the ester, the stereoisomer or the pharmaceutically acceptable salt thereof to a patient or a subject in need.
ANTIBACTERIAL AGENTS
-
, (2014/10/18)
Antibacterial compounds of formula (I) are provided, as well as stereoisomers and pharmaceutically acceptable salts and esters thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of such compounds.
